Home / Sufentanil / United States
US ATC N01AH03 · updated 2 Nov 2026
Sufentanil shortage in United States
Is there a Sufentanil shortage in United States?
Yes. As of 2 Nov 2026, 4 Sufentanil products are reported short in United States, the first since 3 May 2022. No return date has been given. Main reason: other.
Also short in Canada, Austria, Czechia, Norway, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21) limited | Hospira, Inc., a Pfizer Company | 3 May 2022 | not given | Other |
| US | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01) | Hikma Pharmaceuticals USA, Inc. | 3 May 2022 | not given | Other |
| US | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02) | Hikma Pharmaceuticals USA, Inc. | 3 May 2022 | not given | Other |
| US | Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05) | Hikma Pharmaceuticals USA, Inc. | 3 May 2022 | not given | Other |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).